Skip to main content
Premium Trial:

Request an Annual Quote

Sadashi Suzuki and Wendell Wierenga

Premium

Sadashi Suzuki has been hired as Affymetrix’ s general manager for Japan and will work out of the new Affymetrix Japan Tokyo office, which will open in January. Suzuki has 25 years experience in the pharmaceutical, healthcare, and life sciences industries at companies such as Kyowa Hakko Kogyo, Baxter International, and Alcon Laboratories.

Wendell Wierenga, CEO of Syrrx, has joined Ciphergen Biosystems’ board of directors. Wierenga joined Syrrx as CEO in September 2000, after working for Pfizer and Warner-Lambert.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.